GemVax&KAEL Co.Ltd (082270) - Total Liabilities
Based on the latest financial reports, GemVax&KAEL Co.Ltd (082270) has total liabilities worth ₩101.65 Billion KRW (≈ $68.88 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of GemVax&KAEL Co.Ltd to see how much of total assets are deployed in long-term investments.
GemVax&KAEL Co.Ltd - Total Liabilities Trend (2010–2025)
This chart illustrates how GemVax&KAEL Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 082270 total asset value.
GemVax&KAEL Co.Ltd Competitors by Total Liabilities
The table below lists competitors of GemVax&KAEL Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cathay Consolidated Inc
TW:1342
|
Taiwan | NT$1.71 Billion |
|
Thoresen Thai Agencies Public Company Limited
BK:TTA-R
|
Thailand | ฿17.54 Billion |
|
IAR Systems Group AB (publ)
ST:IAR-B
|
Sweden | Skr248.00 Million |
|
Challenger Gold Ltd
AU:CEL
|
Australia | AU$33.37 Million |
|
Orrön Energy AB (publ)
ST:ORRON
|
Sweden | Skr152.48 Million |
|
Natac Natural Ingredients, S.A.
MC:NAT
|
Spain | €87.76 Million |
|
Gersan Elektrik Ticaret ve Sanayi AS
IS:GEREL
|
Turkey | TL1.46 Billion |
|
Grupa Azoty Zaklady Chemiczne Police SA
WAR:PCE
|
Poland | zł2.77 Billion |
Liability Composition Analysis (2010–2025)
This chart breaks down GemVax&KAEL Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See GemVax&KAEL Co.Ltd net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.78 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.64 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GemVax&KAEL Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GemVax&KAEL Co.Ltd (2010–2025)
The table below shows the annual total liabilities of GemVax&KAEL Co.Ltd from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩101.65 Billion ≈ $68.88 Million |
-16.51% |
| 2024-12-31 | ₩121.74 Billion ≈ $82.50 Million |
+348.65% |
| 2023-12-31 | ₩27.13 Billion ≈ $18.39 Million |
+61.60% |
| 2022-12-31 | ₩16.79 Billion ≈ $11.38 Million |
-8.50% |
| 2021-12-31 | ₩18.35 Billion ≈ $12.44 Million |
-22.22% |
| 2020-12-31 | ₩23.59 Billion ≈ $15.99 Million |
-65.42% |
| 2019-12-31 | ₩68.23 Billion ≈ $46.24 Million |
+16.07% |
| 2018-12-31 | ₩58.78 Billion ≈ $39.84 Million |
-37.27% |
| 2017-12-31 | ₩93.71 Billion ≈ $63.51 Million |
-31.22% |
| 2016-12-31 | ₩136.25 Billion ≈ $92.34 Million |
+2.81% |
| 2015-12-31 | ₩132.53 Billion ≈ $89.81 Million |
+112.55% |
| 2014-12-31 | ₩62.35 Billion ≈ $42.26 Million |
-20.50% |
| 2013-12-31 | ₩78.43 Billion ≈ $53.15 Million |
+9.38% |
| 2012-12-31 | ₩71.70 Billion ≈ $48.59 Million |
+24.38% |
| 2011-12-31 | ₩57.65 Billion ≈ $39.07 Million |
+226.40% |
| 2010-12-31 | ₩17.66 Billion ≈ $11.97 Million |
-- |
About GemVax&KAEL Co.Ltd
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution p… Read more